Gastric Cancer: Personalized Immunotherapy Study

We are exploring new personalized immunotherapy treatments for patients with advanced gastric cancer. The goal is to see if these targeted therapies can improve outcomes for those with recurrent or metastatic disease.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Bordeaux
Hépato-Gastroentérologie
Canéjan, France
Centre Hospitalier Regional De Marseille
Hépatogastroentérologie
Marseille, France
Hospices Civils De Lyon
Oncologie médicale
Oullins, France

Sponsor: Hospices Civils De Lyon
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.